Tip: Need to know the basics about Gallbladder Cancer? Click here.
Pro-Pharmaceuticals Reports Progress in Phase II Trials of Biliary Cancer Drug
Pro-Pharmaceuticals, Incorporated, (AMEX: PRW) is reporting promising preliminary results in their Phase II trial of a first-line treatment for biliary cancer. Participants in the study received the company’s developmental drug, DAVANAT, combined with another common anti-cancer agent, 5-FU. To date, four of the five patients who have received dosing have stabilized their disease with one [...]
click here to read full article...